| Receptor tyrosine kinases as druggable targets in glioblastoma: Do signaling pathways matter? A Qin, A Musket, PR Musich, JB Schweitzer, Q Xie Neuro-oncology advances 3 (1), vdab133, 2021 | 41 | 2021 |
| Overexpression of HGF/MET axis along with p53 inhibition induces de novo glioma formation in mice Y Qin, A Musket, J Kou, J Preiszner, BR Tschida, A Qin, CA Land, B Staal, ... Neuro-Oncology Advances 2 (1), vdaa067, 2020 | 11 | 2020 |
| Tyrosine kinase signaling-independent MET-targeting with CAR-T cells A Qin, Y Qin, J Lee, A Musket, M Ying, G Krenciute, FM Marincola, ZQ Yao, ... Journal of translational medicine 21 (1), 682, 2023 | 1 | 2023 |
| Alkaline aqueous solution promoted debromination of 1, 2 dibromo-fluorocarbons–A convenient method for electron deficient perfluorovinyl ethers H Mei, R McCloud, F Ibrahim, C Nworie, A Musket Tetrahedron Letters 58 (21), 2026-2030, 2017 | 1 | 2017 |
| PKIB, a Novel Target for Cancer Therapy A Musket, JP Moorman, J Zhang, Y Jiang International Journal of Molecular Sciences 25 (9), 4664, 2024 | | 2024 |
| The application of radionuclide therapy for breast cancer A Musket, S Davern, BM Elam, PR Musich, JP Moorman, Y Jiang | | 2024 |
| MET Alterations in Glioblastoma: Characterization of Patient-Derived Xenografts and Therapeutic Strategies A Musket East Tennessee State University, 2023 | | 2023 |
| Neuro-Oncology Advances Y Qin, A Musket, J Kou, J Preiszner, BR Tschida, A Qin, CA Land, B Staal, ... | | 2021 |
| 136 Targeting MET with chimeric antigen receptor T cells in hepatocellular carcinoma Y Qin, A Qin, A Musket, J Lee, Z Yao, G Krenciute, Q Xie Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | | 2020 |
